The industry’s only global and open clinical AI SaaS platform aimed at optimizing clinical workflows, reducing physician burnout and improving clinical outcomes
Cambridge, Massachusetts, May 8, 2023 /PRNewswire/ — TeraRecon, ConcertAI, a leader in the advanced visualization and clinical AI SaaS category, has announced the launch of its next-generation enhanced Eureka Clinical AI platform. Designed to support communication infrastructure and enable collaboration across care teams, the platform serves as an end-to-end clinical application that integrates multiple AI algorithms and workflows. This latest release expands Eureka Clinical AI to further streamline clinical solutions and care coordination with support for longitudinal AI analytics, desktop chat, and coordinated multi-AI algorithmic workflows.
“The Eureka Clinical AI Platform is unique in that it supports third-party customer-developed AI algorithms and TeraRecon-developed AI algorithms on one integrated and open AI clinical platform. Jeff Elton, Ph.D. CEO of ConcertAI. Dr. Elton said: As a foundation of trust and usefulness, we provide the ability to interact directly with AI, such as accepting or rejecting AI recommendations. We are currently building an AI ecosystem to grow these dynamic capabilities. with new partners joining every week. Dedicated therapeutic solutions such as the new Neuro Suite. ”
“The high-performance AI ecosystem is basically built on four main pillars. Dan McSweeney, President of TeraRecon. “The first is the comprehensive ability to host all forms of AI, including customer-developed algorithms, TeraRecon-developed algorithms, and third-party algorithms. Physician-centric in that it reaffirms the physician’s role in the decision-making process, and the third is integration, where the AI platform acts as a single point of access for integrating AI solutions. , which minimizes the burden of procuring new AI algorithms, standardizes the deployment process, and integrates seamlessly into the provider’s enterprise imaging system, enabling the ecosystem to make the performance of AI solutions completely transparent to the AI and the scope of where it should be applied. It has to be built, and robust, and TeraRecon’s solution is the only one on the market today that delivers on those promises.”
“We are committed to continuously improving the products we offer,” added Dr. Elton. “Following the successful launch of the Eureka Clinical AI platform last fall, we received great insights from our users and clinicians to develop this enhanced version of Eureka. This new platform enables sequential AI analytics. This is a feature that our customers have told us: it helps them improve diagnostic accuracy and monitor disease progression.”
Eureka Clinical AI is a state-of-the-art AI SaaS image interpretation and clinical decision enhancement solution. It is unique in that it is open to 3rd party AI algorithms and allows you to centrally manage all your AI interpretation solutions with seamless PACS or EMR integration. Multidisciplinary care teams can review results and receive mobile alerts to review AI findings to ensure optimal and timely patient intervention, management and coordinated care delivery. increase.
Learn more about the capabilities and algorithms of the Eureka Clinical AI platform across neurology, radiology, cardiology, oncology and more at https://www.terarecon.com/artificial-intelligence.
About TeraRecon: TeraRecon, a ConcertAI Company Serving 1,300 Clinical Sites Worldwide, is Best in KLAS as an AI-Powered KLAS Solution Provider for Radiology, Oncology, Cardiology, Neurology, and Vascular Surgery is. Winner of 2020, 2021 and 2022 KLAS Category Leader Advanced Visualization, the TeraRecon solution is independent of any manufacturer’s imaging equipment or PACS system and provides a single, integrated and simplified clinical workflow. enable, improve efficiency and deliver actionable, physician-driven insights. For more information, please visit https://www.terarecon.com/.
About ConcertAI: ConcertAI is a leader in real-world evidence (RWE) and AI technology solutions for life sciences and healthcare. Our mission is to collaborate with leading biomedical innovators, healthcare providers, and medical societies to accelerate patient insights and outcomes through cutting-edge real-world data, AI technology, and scientific expertise. That’s it. For more information, please visit https://www.concertai.com/.
Media contact: Megan Duero, [email protected]
source concert
